Amy M. Trombly's most recent trade in Sonoma Pharmaceuticals Inc. was a trade of 10,000 Restricted Stock Units done . Disclosure was reported to the exchange on Jan. 2, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Sonoma Pharmaceuticals Inc.
|
Amy M. Trombly | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 10,000 | 18,685 | - | - | Restricted Stock Units | |
Sonoma Pharmaceuticals Inc.
|
Amy M. Trombly | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 53,586 | 153,586 (8%) | 3% | - | Common Stock, $0.0001 par value | |
Sonoma Pharmaceuticals Inc.
|
M. Amy Trombly | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 60,000 | 173,648 | - | - | Stock option (right to buy) | |
Sonoma Pharmaceuticals Inc.
|
Trombly Amy M. | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 100,000 | 213,648 (12%) | 5% | - | Common Stock, $0.0001 par value |